Biotoxtech Co., Ltd. (KOSDAQ: 086040)

South Korea flag South Korea · Delayed Price · Currency is KRW
3,320.00
-70.00 (-2.06%)
Dec 20, 2024, 9:00 AM KST
-44.20%
Market Cap 52.19B
Revenue (ttm) 38.44B
Net Income (ttm) -4.41B
Shares Out 15.72M
EPS (ttm) -301.72
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 12,294
Open 3,405.00
Previous Close 3,390.00
Day's Range 3,310.00 - 3,410.00
52-Week Range 2,905.00 - 7,430.00
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date Mar 20, 2025

About Biotoxtech

Biotoxtech Co., Ltd. engages in the safety evaluation of synthetic medicines, biomedicines, cell therapy products, gene therapy products, health functional foods, chemicals, and pesticides in South Korea. It is involved in testing and substance screening, clinical pathology and histopathology work, and consulting and government affairs related to non-clinical trials, as well as new drug development. The company’s safety evaluation research field includes general toxicity test, carcinogenicity studies, local toxicity studies, reproductive and de... [Read more]

Industry Medical Laboratories
Founded 2000
Employees 198
Stock Exchange KOSDAQ
Ticker Symbol 086040
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.